Home > Healthcare > Biotechnology > Biopharma > Cancer Stem Cells Therapy Market

Cancer Stem Cells Therapy Market Share

  • Report ID: GMI7152
  • Published Date: Oct 2023
  • Report Format: PDF

Cancer stem cells therapy Market Share

The key players operating in this market have established themselves through, continuous research & development, and a strong market presence. Gamida Cells, AbbVie Inc, and Astellas Pharma Inc account significant market share. These prominent players thrive through a combination of strategic approaches, diverse product portfolio, research and development initiatives, market understanding, and regulatory compliance.

Market players operating in the cancer stem cells therapy is as mentioned below:

  • Gamida Cells
  • AbbVie Inc
  • Astellas Pharma Inc
  • Novadip Biosciences
  • ReNeuron Group plc
  • Celyad
  • Adna GmBH
  • Thermo Fisher Scientific
  • Genentech Inc
  • Merck KGaA
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for cancer stem cells therapy was worth USD 4.4 billion in revenue in 2022 and may record USD 12 billion by end of 2032 due to the increasing cases of cancer along with the growing private and public initiatives

The breast type cancer segment accounted for 24.4% of the market share in 2022 propelled by the increased funding and public awareness

North America industry size is expected to grow at 10% CAGR from 2023-2032 owing to presence of exceptionally advanced healthcare infrastructure, featuring state-of-the-art hospitals, research institutions, and biotechnology companies

Gamida Cells, AbbVie Inc, Astellas Pharma Inc, Novadip Biosciences, ReNeuron Group plc, Celyad, Adna GmBH, Thermo Fisher Scientific, Genentech Inc, and Merck KGaA are some of the major cancer stem cells therapy firms

Cancer Stem Cells Therapy Market Scope

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Base Year: 2022
  • Companies covered: 10
  • Tables & Figures: 256
  • Countries covered: 19
  • Pages: 120
 Download Free Sample